← Leaderboards
Anil Kumar Jaiswal
Baylor College Of Medicine
$15,017,310
Attributed
$15,017,310
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$15,017,310 · 5
By mechanism
R01$15,017,310 · 5
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Transfection”
- David Heimbrook · Leidos Biomedical Research, Inc.$94,306,630
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$39,277,975
- Barton F Haynes · Duke University$19,824,751
- William W Hauswirth · University Of Florida$19,491,817
- Michael P Snyder · Yale University$14,582,826
- Larry Arthur$12,814,310
Research focus
TransfectionImmunoprecipitationQuinonesIn VivoPhosphorylationLiverProteinsNqo1 GeneTissuesCytotoxicityRegulationCellsSkinResponseBenzo(A)PyreneChemical CarcinogenesisEnzymesPlayRadiationGenesLaboratory MouseMediatingTumorMalignant Neoplasms
Grant awards (53)
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity$345,375
R01 · FY2016 · ES · contact PI
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity$345,375
R01 · FY2015 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$337,500
R01 · FY2015 · ES · contact PI
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity$341,921
R01 · FY2014 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$334,125
R01 · FY2014 · ES · contact PI
Role and Regulation of INrf2$330,785
R01 · FY2014 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$294,244
R01 · FY2014 · GM · contact PI
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity$345,375
R01 · FY2013 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$330,750
R01 · FY2013 · ES · contact PI
Role and Regulation of INrf2$327,443
R01 · FY2013 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$283,946
R01 · FY2013 · GM · contact PI
Prevention of quinone toxicity and mutagenicity$337,500
R01 · FY2012 · ES · contact PI
Role and Regulation of INrf2$334,125
R01 · FY2012 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$294,244
R01 · FY2012 · GM · contact PI
Prevention of quinone toxicity and mutagenicity$337,500
R01 · FY2011 · ES · contact PI
Role and Regulation of INrf2$334,125
R01 · FY2011 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$294,244
R01 · FY2011 · GM · contact PI
Role and Regulation of INrf2$337,500
R01 · FY2010 · ES · contact PI
Role and Regulation of INrf2$331,034
R01 · FY2009 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$331,034
R01 · FY2009 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$268,725
R01 · FY2009 · GM · contact PI
Role and Regulation of INrf2$331,034
R01 · FY2008 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$331,034
R01 · FY2008 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$268,725
R01 · FY2008 · GM · contact PI
Mechanisms of Bioreductive Drugs Activation$256,010
R01 · FY2008 · CA · contact PI
Role and Regulation of INrf2$337,790
R01 · FY2007 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$337,789
R01 · FY2007 · ES · contact PI
Mechanisms of Bioreductive Drugs Activation$256,010
R01 · FY2007 · CA · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$255,000
R01 · FY2007 · GM · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$19,725
R01 · FY2007 · GM · contact PI
Role and Regulation of INrf2$347,879
R01 · FY2006 · ES · contact PI
Prevention of quinone toxicity and mutagenicity$347,879
R01 · FY2006 · ES · contact PI
Regulation of NAD(P)H:Quinone Oxidoreductases$297,250
R01 · FY2006 · GM · contact PI
Mechanisms of Bioreductive Drugs Activation$264,534
R01 · FY2006 · CA · contact PI
Prevention of quinone toxicity and mutagenicity$356,250
R01 · FY2005 · ES
Role and Regulation of INrf2$356,250
R01 · FY2005 · ES
Mechanisms of Bioreductive Drugs Activation$270,900
R01 · FY2005 · CA
Regulation of NAD(P)H: Quinone Oxidoreductases$242,635
R01 · FY2005 · GM
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$299,000
R01 · FY2004 · ES
Mechanisms of Bioreductive Drugs Activation$270,900
R01 · FY2004 · CA
Regulation of NAD(P)H: Quinone Oxidoreductases$242,635
R01 · FY2004 · GM
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$299,000
R01 · FY2003 · ES
Regulation of NAD(P)H: Quinone Oxidoreductases$242,635
R01 · FY2003 · GM
MECHANISMS OF BIOREDUCTIVE DRUGS ACTIVATION$75,250
R01 · FY2003 · CA
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$299,000
R01 · FY2002 · ES
Regulation of NAD(P)H: Quinone Oxidoreductases$265,666
R01 · FY2002 · GM
MECHANISMS OF BIOREDUCTIVE DRUGS ACTIVATION$167,833
R01 · FY2002 · CA
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$299,000
R01 · FY2001 · ES
MECHANISMS OF BIOREDUCTIVE DRUGS ACTIVATION$162,945
R01 · FY2001 · CA
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$25,000
R01 · FY2001 · ES
PREVENTION OF QUINONE TOXICITY AND MUTAGENICITY$324,000
R01 · FY2000 · ES
REGULATION OF NAD(P)H--QUINONE OXIDOREDUCTASES$189,162
R01 · FY2000 · GM
MECHANISMS OF BIOREDUCTIVE DRUGS ACTIVATION$161,720
R01 · FY2000 · CA